
PreveCeutical Medical
(OTC) PRVCF
PreveCeutical Medical Financials at a Glance
Market Cap
$6.22M
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$1.63M
EPS (TTM)
-$0.00
P/E Ratio
-4.95
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.01
Volume
20,000
Open
$0.01
Price
$0.01
Volume
20,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.04
Estimated Earnings Date
Apr 30, 2026
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.01
Volume
20,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.04
Estimated Earnings Date
Apr 30, 2026
PRVCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PreveCeutical Medical
Industry
Pharmaceuticals
Sector
Health CareCEO
Stephen van Deventer
Website
www.preveceutical.comHeadquarters
Vancouver, BC V6B 0R6, CA
PRVCF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
59%
Return on Assets
-1%
Earnings Yield
-20.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.22M
Shares Outstanding
598.19M
Volume
20.00K
Avg. Volume
16.87K
Financials (TTM)
Gross Profit
-CA$14.41K
Operating Income
-CA$3.36M
EBITDA
-CA$3.35M
Operating Cash Flow
-CA$1.72M
Capital Expenditure
-CA$2.96K
Free Cash Flow
-CA$1.72M
Cash & ST Invst.
CA$10.23K
Total Debt
CA$4.67M
PreveCeutical Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$3.63K
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.22M
N/A
Market Cap/Employee
$888.73K
N/A
Employees
7
N/A
Net Income
CA$1.21M
+601.9%
EBITDA
-CA$717.65K
-356.6%
Quarterly Fundamentals
Total Cash
CA$10.23K
-82.7%
Total Debt
CA$4.67M
+4.8%
Accounts Receivable
CA$1.01M
+3607.5%
Inventory
CA$0.00
N/A
Long Term Debt
CA$0.00
-100.0%
Short Term Debt
CA$4.67M
+6.3%
Return on Assets
-1.12%
N/A
Return on Invested Capital
59.39%
N/A
Free Cash Flow
-CA$533.95K
-701.4%
Operating Cash Flow
-CA$533.95K
-710.1%